[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-358700-105":59,"doc-detail-358700-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","tet1-as-a-master-regulator-controlling-gpx4-dependent-and-independent-ferroptosis-surveillance-in-acute-myeloid-leukemia","TET1 as a master regulator controlling GPX4-dependent and-independent ferroptosis surveillance in acute myeloid leukemia","","Ferroptosis is an iron-dependent, lipid-peroxidation-driven programmed cell death with strong therapeutic promise, yet many cancers resist ferroptosis induction. While GPX4 is established as a suppressor, the epigenetic control of GPX4-related and GPX4-independent surveillance remains unclear. Through genome-wide screening, researchers identify TET1 as a master regulator of ferroptosis susceptibility in acute myeloid leukemia, shaping 5hmC at GCLC and activating NFκB to upregulate GCH1. Dual targeting of TET1/GCLC/GCH1 with low-dose inducers shows potent activity against both ferroptosis-sensitive and -resistant AML.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tet1-as-a-master-regulator-controlling-gpx4-dependent-and-independent-ferroptosis-surveillance-in-acute-myeloid-leukemia/358700/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tet1-as-a-master-regulator-controlling-gpx4-dependent-and-independent-ferroptosis-surveillance-in-acute-myeloid-leukemia/358700.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role does TET1 play in ferroptosis surveillance in acute myeloid leukemia?","Question",{"text":113,"@type":114},"TET1 functions as a master regulator that controls ferroptosis susceptibility by coordinating GPX4-dependent and GPX4-independent defense programs in AML.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does TET1 influence GPX4-dependent ferroptosis defense?",{"text":118,"@type":114},"TET1 enhances 5hmC deposition at the GCLC promoter, activating glutathione/γ-glutamyl-peptide metabolism to strengthen GPX4-dependent protection.",{"name":120,"@type":111,"acceptedAnswer":121},"How can resistant AML cells be targeted based on TET1-related mechanisms?",{"text":122,"@type":114},"Co-targeting TET1 with GCLC and GCH1 using low-dose ferroptosis inducers produces potent therapeutic effects against both ferroptosis-sensitive and ferroptosis-resistant AML.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},358700,1790153492,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article [https://doi.org/10.1038/s41467-026-68509-x](https://doi.org/10.1038/s41467-026-68509-x)  \nTET1 as a master regulator controlling GPX4-dependent and-independent ferroptosis surveillance in acute myeloid leukemia  \nReceived: 7 March 2025  \n\n| Accepted: 8 January 2026 |\n| --- |\n| |\n| Check for updates |\n\nLingling Yang1,2,3,8, Jun Lu1,2,3,8, Weina Yun1,2,3,8, Xinquan Yang4, Jie Sun5, Chaodong Ge6, Fei Han1,2,3, Xiang Li1,2,3, Junxia Min 4, He Huang5, Fudi Wang 6,7  & Xi Jiang1,2,3   \nFerroptosis, an iron-dependent, lipid peroxidation-driven programmed cell death, holds substantial promise for cancer therapy, yet its translational potential is hindered by widespread intrinsic resistance. While glutathione peroxidase 4 (GPX4) is a well-established ferroptosis suppressor, the epigenetic circuitry coordinating GPX4-related mechanisms remains elusive. Here, via genome-wide screening, we identify ten-eleven translocation 1 (TET1)—a key mediator of DNA 5-hydroxymethylation—as a master controller of cancer cell ferroptosis susceptibility. In acute myeloid leukemia (AML), TET1 enhances 5hmC deposition at the glutamate-cysteine ligase catalytic subunit (GCLC) promoter to activate glutathione/γ-glutamyl-peptide metabolism, fortifying GPX4-dependent defense. Concurrently, TET1 activates NFκB signaling to upregulate GTP cyclohydrolase-1 (GCH1), conferring GPX4-independent ferroptosis resistance. Critically, co-targeting TET1/GCLC/GCH1 with low-dose ferroptosis inducers exhibits potent therapeutic effects against both ferroptosis-sensitive and-resistant AML. Our work positions TET1 as a pivotal epigenetic hub governing ferroptosis surveillance, and provides a translatable strategy to overcome ferroptosis resistance in cancer, withAML as a paradigm.  \nFerroptosis, a non-apoptotic form of programmed cell death driven by iron-dependent lipid peroxidation, is closely associated with cancer. Dysregulation of ferroptosis-related pathways, including the System Xc- -GPX4 axis, iron metabolism, and lipid peroxidation, contributes to cancer progression and offers optional therapeutic vulnerabilities for aggressive malignancies1. However, cancer cells exhibit heterogeneous susceptibility to  \nferroptosis2,3. Although ferroptosis induction has emerged as a promising approach to treat responsive cancers (e.g., originally, RAS-mutated cancer cells), ferroptotic resistance of irresponsive cancer cells (e.g., some breast and colon tumors) restricts its clinical applicability4–8. Therefore, it is important to identify the key mechanism that determines the disparity of cancer cell vulnerability to ferroptosis.  \n1Department of Pharmacology, Bone Marrow Transplantation Center of the First Afﬁliated Hospital, Zhejiang University School of Medicine, and Zhejiang Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, Zhejiang, China. 2Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, Zhejiang, China. 3Institute of Hematology, Zhejiang University and Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, Zhejiang, China. 4The First Afﬁliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. 5Bone Marrow Transplantation Center of the First Afﬁliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. 6The Second Afﬁliated Hospital, School of Public Health, State Key Laboratory of Experimental Hematology, Zhejiang University School of Medicine, Hangzhou, China. 7Global Innovation Institute of Element Science (GIIES-JLU), The First Hospital of Jilin University, Changchun, China. 8These authors contributed equally: Lingling Yang, Jun Lu, Weina Yun. e-mail: [fwang@zju.edu.cn](fwang@zju.edu.cn); [xjiang@hznu.edu.cn](xjiang@hznu.edu.cn)  \nCancer cells rely on sophisticated surveillance mechanisms to maintain cellular homeostasis and evad","cbCaii5y8shoyYuf","https://ap.wps.com/l/cbCaii5y8shoyYuf","pdf",2197951,17,"English","# Introduction\n## Ferroptosis and therapeutic resistance\n## GPX4-dependent surveillance and glutathione metabolism\n## GPX4-independent surveillance pathways\n## Epigenetic regulation and TET enzymes","[{\"question\":\"What role does TET1 play in ferroptosis surveillance in acute myeloid leukemia?\",\"answer\":\"TET1 functions as a master regulator that controls ferroptosis susceptibility by coordinating GPX4-dependent and GPX4-independent defense programs in AML.\"},{\"question\":\"How does TET1 influence GPX4-dependent ferroptosis defense?\",\"answer\":\"TET1 enhances 5hmC deposition at the GCLC promoter, activating glutathione/γ-glutamyl-peptide metabolism to strengthen GPX4-dependent protection.\"},{\"question\":\"How can resistant AML cells be targeted based on TET1-related mechanisms?\",\"answer\":\"Co-targeting TET1 with GCLC and GCH1 using low-dose ferroptosis inducers produces potent therapeutic effects against both ferroptosis-sensitive and ferroptosis-resistant AML.\"}]","TET1 as a master regulator controlling GPX4-dependent and-independent ferroptosis surveillance in acute myeloid leukemia | PDF",1790135010,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8cc3d57782dd974d74bbdf3929bcd48.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/510bb73bdd7de97695b1ee91254bc3e3.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d349f1efe7292c9bf521d5b38a42318.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/241dbee97b45348bf8d5d12f4c3e2aaa.webp",980,1301]